B. Graham

发表

O-58 Quality of life in a trial of adjuvant chemotherapy for early stage completely resected non-small cell lung cancer (NCIC CTG BR.10)

L. Seymour, R. Livingston, K. Ding, 2003 .

Randomized phase IIb trial comparing two schedules of docetaxel (D) plus estramustine (E) for metastatic hormone refractory prostate cancer (HRPC).

L. Schwartzberg, R. Birch, L. Kalman, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experience.

L. Seymour, R. Livingston, K. Ding, 2007, Lung cancer.

The CCTG PA.7 trial: A randomized phase II study of gemcitabine and nab-paclitaxel vs. gemcitabine, nab-paclitaxel, durvalumab, and tremelimumab as 1st line therapy in metastatic pancreatic ductal adenocarcinoma (PDAC).

D. Tu, N. Dhani, P. Kavan, 2017 .

P1-06-08: Effect of Treatment Emergent Symptoms on Relapse Free Survival: NCIC CTG MA.12 a Randomized Placebo-Controlled Trial of Tamoxifen after Adjuvant Chemotherapy in Pre-Menopausal Women in Early Breast Cancer.

K. Gelmon, A. L. Maître, V. Bramwell, 2011 .

Updated survival analysis of JBR.10: A randomized phase III trial of vinorelbine/cisplatin versus observation in completely resected stage IB and II non-small cell lung cancer (NSCLC).

L. Seymour, D. Gandara, K. Ding, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.

Lesley Seymour, L. Seymour, K. Ding, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

Robert Livingston, Lesley Seymour, Ming-Sound Tsao, 2005, The New England journal of medicine.

Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.

Brian Findlay, Lesley Seymour, Ming-Sound Tsao, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial).

C. Gridelli, D. Coyle, L. Seymour, 2013, Lung cancer.

Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature.

L. Seymour, R. Livingston, K. Ding, 2005, Lung cancer.

Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.

A. Bezjak, L. Seymour, R. Livingston, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.

L. Seymour, R. Livingston, K. Ding, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12).

D. Tu, V. Bramwell, K. Pritchard, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Quality of life (QOL) impact of adjuvant chemotherapy for early stage non-small cell lung cancer (NSCLC): Final analysis of JBR.10 randomized trial

A. Bezjak, L. Seymour, K. Ding, 2007 .